Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-18

Clinical Trial Update: Pregabalin in Treatment of Postdural Puncture Headache [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating pregabalin for treating postdural puncture headache has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lyrica (Pregabalin)

Snippet

Sponsor: Al-Azhar University | Conditions: Postdural Puncture Headache | Phase 3 | Status: COMPLETED